Evaluation of Multi-Target and Single-Target Liposomal Drugs for the Treatment of Gastric Cancer (original) (raw)

Progress in Lipid Research, 2005

View PDFchevron_right

The Cancer Treatment by Using Liposome as Drug Delivery Systems and Its Applications: An Extensive Review

Harsh Trivedi

2020

View PDFchevron_right

Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs

Gann Ting

PLoS ONE, 2013

View PDFchevron_right

Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro

Edgar Luther

Journal of Controlled Release, 2015

View PDFchevron_right

Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems

Roshan Goswami

Pharmaceuticals

View PDFchevron_right

Liposome Technology for Cancer Treatment

Mihika Yeolekar

The Bombay Technologist, 2020

View PDFchevron_right

Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma

Maryam Ebrahimi NIk

Scientific Reports, 2019

View PDFchevron_right

Liposomes : A Review In Cancer Therapy

tushar matta

2016

View PDFchevron_right

A new application for liposomes in cancer therapy

Monique Vingerhoeds

FEBS Letters, 1993

View PDFchevron_right

Liposome and Their Applications in Cancer Therapy

Himanshu Pandey

Brazilian Archives of Biology and Technology, 2016

View PDFchevron_right

Fighting cancer: From the bench to bedside using second generation cationic liposomal therapeutics

Robert Campbell

Journal of Pharmaceutical Sciences, 2009

View PDFchevron_right

Liposomal Formulations In Cancer Therapy: Passive Versus Active Targeting

kaushika patel

Asian Journal of Pharmaceutical Research and Development, 2019

View PDFchevron_right

Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor

amr S Abu Lila

Journal of Controlled Release, 2010

View PDFchevron_right

Liposomal therapies in oncology: does one size fit all?

Hugo Prazeres

Cancer chemotherapy and pharmacology, 2018

View PDFchevron_right

Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts

Michael Amantea

PubMed, 1998

View PDFchevron_right

Potential antitumor activity of novel DODAC/PHO-S liposomes

Durvanei Maria

International Journal of Nanomedicine, 2016

View PDFchevron_right

Liposomal nanomedicines as anticancer therapeutics: Beyond targeting tumor cells

Raymond Schiffelers

International Journal of Pharmaceutics, 2008

View PDFchevron_right

Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: Synergy or antagonism?

amr S Abu Lila

International Journal of Pharmaceutics, 2012

View PDFchevron_right

Combination therapy of metronomic S-1 dosing with oxaliplatin-containing polyethylene glycol-coated liposome improves antitumor activity in a murine colorectal tumor model

Tatsuhiro Ishida

Cancer Science, 2010

View PDFchevron_right

Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model

Gann Ting

Nuclear Medicine and Biology, 2010

View PDFchevron_right

EXPLORING LIPID-BASED DRUG DELIVERY IN CANCER THERAPY VIA LIPOSOMAL FORMULATIONS

Asian Journal of Pharmaceutical and Clinical Research Journal

Asian Journal of Pharmaceutical and Clinical Research, 2022

View PDFchevron_right

Pharmacokinetics and Dosimetry of 111 In/ 188 Re-Labeled PEGylated Liposomal Drugs in Two Colon Carcinoma-Bearing Mouse Models

Hsin-ell Wang, Gann Ting

Cancer Biotherapy & Radiopharmaceuticals, 2011

View PDFchevron_right

Review Article Liposomes: A Targeted Drug Delivery System-A Review *Corresponding Author

Asha Roshan

2015

View PDFchevron_right

Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent

Vincenzo Tumiatti

Drug delivery, 2013

View PDFchevron_right

Ligand-targeted liposomal anticancer drugs

Theresa Allen

Progress in Lipid Research, 2003

View PDFchevron_right

Current trends in the use of liposomes for tumor targeting

Vladimir Torchilin

Nanomedicine, 2013

View PDFchevron_right

Recent Trends in Nano Drug Delivery Systems to Treat Cancers: With Special Focus on Liposomal Drug Delivery Systems

yashwant pathak

2024

View PDFchevron_right

In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug

Maha Saad

Journal of Controlled Release, 2006

View PDFchevron_right

Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment

Ibrahim Tolaymat

Pharmaceutics

View PDFchevron_right

Targeting Liposomal Chemotherapy via Both Tumor Cell-Specific and Tumor Vasculature-Specific Ligands Potentiates Therapeutic Efficacy

Annalisa Pezzolo, Danilo Marimpietri, A. Corti, Theresa Allen

Cancer Research, 2006

View PDFchevron_right

Improved In Vitro Anti-Tumoral Activity, Intracellular Uptake and Apoptotic Induction of Gemcitabine-Loaded Pegylated Unilamellar Liposomes

Cinzia A Ventura

Journal of Nanoscience and Nanotechnology, 2008

View PDFchevron_right

Liposomes for targeting hepatocellular carcinoma: Use of conjugated arabinogalactan as targeting ligand

Mangal Nagarsenker

International Journal of Pharmaceutics, 2014

View PDFchevron_right

Liposomal Drug Delivery Systems: An Update Review

abdus samad

Current Drug Delivery, 2007

View PDFchevron_right

Recent Advances in Liposomal Drug Delivery: A Review

Vijaykumar Nekkanti

Pharmaceutical nanotechnology, 2015

View PDFchevron_right

Evaluation of Multi-Target and Single-Target Liposomal Drugs for the Treatment of Gastric Cancer (original) (raw)

Related papers